PathoVax's Incubator/Accelerator - IV Round

PathoVax raised a round of funding on July 12, 2017. Investors include Harvard Venture Incubation Program.

PathoVax is a biotech company developing a cost-effective human papillomavirus (HPV) vaccine machine with universal protection. PathoVax's pilot vaccine RGVax promises to provide protection against al…

Articles about PathoVax's Incubator/Accelerator - IV Round: